Cite

HARVARD Citation

    Boekhout, A. et al. (2021). Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls. Acta oncologica. pp. 69-77. [Online]. 
  
Back to record